Medicamen Biotech consolidated net profit rises 82.88% in the September 2025 quarter
(15 Nov 2025)

Back
Net profit of Medicamen Biotech rose 82.88% to Rs 2.67 crore in the quarter ended September 2025 as against Rs 1.46 crore during the previous quarter ended September 2024. Sales rose 5.43% to Rs 47.17 crore in the quarter ended September 2025 as against Rs 44.74 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales47.1744.74 5
OPM %10.9411.87 -
PBDT4.544.56 0
PBT2.681.96 37
NP2.671.46 83

Copyright © 2024 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)

x
  • QR-CodeNew